Dorian LPG
LPG
Hutchmed (China)
HCM
Collegium Pharmaceutical
COLL
4
Halozyme Therapeutics
HALO
5
Precision Drilling
PDS
(FY)Sep 30, 2024 | (Q4)Sep 30, 2024 | (FY)Sep 30, 2023 | (Q4)Sep 30, 2023 | (Q3)Jun 30, 2023 | (FY)Sep 30, 2022 | (FY)Sep 30, 2021 | |
---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | |||||||
Cash flow from continuing operating activities | 201.95%826.54K | 156.51%659.16K | -183.74%-810.74K | -1.17M | 907.31K | 187.35%968.19K | -1.11M |
Net income from continuing operations | -36.21%962.74K | -260.04%-250.6K | 35,849.22%1.51M | --156.59K | --510.43K | -101.55%-4.22K | --272.51K |
Depreciation and amortization | 37.33%53.54K | 36.43%15.49K | 367.06%38.99K | --11.35K | --10.04K | 1,683.76%8.35K | --468 |
Deferred tax | -515.23%-123.96K | -1,117.77%-161.18K | 78.78%-20.15K | ---13.24K | --9.83K | -289.86%-94.95K | ---24.35K |
Other non cash items | 392.35%189.31K | 1,535.81%159.88K | -34.93%38.45K | --9.77K | --10.1K | 63.47%59.09K | --36.15K |
Change In working capital | 71.32%-681.43K | 118.96%259.19K | -438.62%-2.38M | ---1.37M | --437.49K | 149.18%701.57K | ---1.43M |
-Change in receivables | 26.58%-1.58M | -5.15%-1.12M | -723.28%-2.15M | ---1.06M | --307.11K | -20.82%344.2K | --434.71K |
-Change in inventory | -92.89%10.88K | -6.72%8.03K | 998.21%153.03K | --8.61K | --8.65K | 107.26%13.93K | ---191.96K |
-Change in prepaid assets | -144.79%-48.71K | -70.11%27.11K | 208.70%108.76K | --90.71K | --435.29K | -79.71%-100.06K | ---55.68K |
-Change in payables and accrued expense | 290.15%454.46K | -22.89%318.09K | -125.92%-239K | --412.52K | --487K | 179.99%922.21K | --329.37K |
-Change in other current liabilities | -1.82%-43.31K | -15.10%-13.38K | -16.14%-42.53K | ---11.63K | ---10.27K | 9.73%-36.62K | ---40.57K |
-Change in other working capital | 347.01%520.26K | 228.26%1.03M | 52.36%-210.62K | ---806.54K | ---790.29K | 76.76%-442.09K | ---1.9M |
Cash from discontinued investing activities | |||||||
Operating cash flow | 201.95%826.54K | 156.51%659.16K | -183.74%-810.74K | ---1.17M | --907.31K | 187.35%968.19K | ---1.11M |
Investing cash flow | |||||||
Cash flow from continuing investing activities | -202.43%-202.74K | -114.70%-121.87K | 144.26%197.92K | 828.93K | -747.26K | -958.50%-447.17K | -42.25K |
Net PPE purchase and sale | -338.99%-121.72K | -47,459.92%-121.72K | 83.47%-27.73K | --257 | --50 | -538.37%-167.7K | ---26.27K |
Net intangibles purchase and sale | -449.71%-81.02K | -213.14%-155 | 28.94%-14.74K | --137 | ---7.78K | -29.83%-20.74K | ---15.98K |
Net other investing changes | ---- | ---- | 192.91%240.39K | --828.54K | ---739.53K | ---258.73K | ---- |
Cash from discontinued investing activities | |||||||
Investing cash flow | -202.43%-202.74K | -114.70%-121.87K | 144.26%197.92K | --828.93K | ---747.26K | -958.50%-447.17K | ---42.25K |
Financing cash flow | |||||||
Cash flow from continuing financing activities | -81.96%83.64K | 22.17%-21.72K | 324.59%463.55K | -27.91K | -67.56K | -114.26%-206.39K | 1.45M |
Net issuance payments of debt | -69.33%144.38K | 141.31%8.58K | 328.06%470.69K | ---20.76K | ---67.56K | -114.26%-206.39K | --1.45M |
Net other financing activities | -750.16%-60.74K | ---30.3K | ---7.15K | ---- | ---- | ---- | ---- |
Cash from discontinued financing activities | |||||||
Financing cash flow | -81.96%83.64K | 22.17%-21.72K | 324.59%463.55K | ---27.91K | ---67.56K | -114.26%-206.39K | --1.45M |
Net cash flow | |||||||
Beginning cash position | -27.67%414.62K | -21.26%606.79K | 83.21%573.27K | --770.64K | --719.36K | 2,313.05%312.9K | --12.97K |
Current changes in cash | 573.92%707.44K | 241.11%515.56K | -147.45%-149.27K | ---365.37K | --92.48K | 6.18%314.62K | --296.3K |
Effect of exchange rate changes | 476.10%35.26K | 273.87%34.96K | 82.72%-9.37K | --9.35K | ---41.2K | -1,593.86%-54.26K | --3.63K |
End cash Position | 179.13%1.16M | 179.13%1.16M | -27.67%414.62K | --414.62K | --770.64K | 83.21%573.27K | --312.9K |
Free cash flow | 173.11%623.8K | 146.08%537.29K | -209.42%-853.21K | ---1.17M | --899.58K | 167.77%779.75K | ---1.15M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD |